BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Khanal, P. Nepal's Childhood Mortality Falls by Half As Vaccinations Rise Tenfold Bull.World Health Organ 2002, 80 (12): 988­989.
Konishi, E. and Suzuki, T. Ratios of Subclinical to Clinical Japanese Encephalitis (JE) Virus Infections in Vaccinated Populations: Evaluation of an
Inactivated JE Vaccine by Comparing the Ratios With Those in Unvaccinated Populations Vaccine 11­22­2002, 21 (1­2): 98­107
Korang, K., Ghohestani, R., Krieg, T., Uitto, J., and Hunzelmann, N. Exacerbation of Pemphigus Foliaceus After Tetanus Vaccination Accompanied by
Synthesis of Auto­Antibodies Against Paraneoplastic Pemphigus Antigens Acta Derm.Venereol. 2002, 82 (6): 482­483.
Kosuwon, P., Wasi, C., Sutra, S., Kositanont, U., Hutagalung, Y., and Bock, H. L. Flexibility in the Administration Schedule of Varicella Vaccination in
Healthy Adolescents and Young Adults. Asian Pac.J Allergy Immunol. 2002, 20 (4): 241­245.
Krause, G., Blackmore, C., Wiersma, S., Lesneski, C., Gauch, L., and Hopkins, R. S. Mass Vaccination Campaign Following Community Outbreak of
Meningococcal Disease Emerg.Infect.Dis. 2002 Dec, 8 (12): 1398­1403.
Kribs­Zaleta, C.M., Martcheva, M. Vaccination strategies and backward bifurcation in an age­since­infection structured model. Math Biosci. 2002 May­
Jun;177­178:317­32.
Krishna, M. T. and Salvi, S. S. BCG vaccination and prevention of allergic disease Pediatrics. 2002, 109 (2): 346­347.
Krishna, M. T. and Salvi, S. S. Could Administration of Bacille Calmette­Guerin Vaccination at Birth Protect From the Development of Asthma and Allergic
Diseases in the Western World? Has This Question Been Adequately Investigated? Pediatr.Allergy Immunol. 2002, 13 (3): 172­176.
Kudesia, G., Partridge, S., Farrington, C. P., and Soltanpoor, N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine
strategy J.Clin.Pathol. 2002, 55 (2): 154­155.
Kunz, C. Vaccination Against TBE in Austria: the Success Story ContinuesInt.J.Med.Microbiol. 2002, 291 Suppl 33:56­7. (): 56­57.
Kuvakina, V. I., Golovina, L. I., Mishina, A. I., Skirda, T. A., Bobyleva, G. V., Mikheeva, N. G., Chernyshova, T. F., Temper, R. M., and Ermolenko, Z. N.
Evaluation of the Immunological Activity and Safety of Group B Meningococcal Vaccine Prepared From a Natural Complex of Specific Polysaccharide and
Outer Membrane Proteins Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 33­37. [Article in Russian]
Kyaw, M. H., Holmes, E. M., Chalmers, J., Jones, I. G., and Campbell, H. A Survey of Vaccine Coverage and Antibiotic Prophylaxis in Splenectomised
Patients in Scotland J.Clin.Pathol. 2002, 55 (6): 472­474.
Lacson, A. G., D'Cruz, C. A., Gilbert­Barness, E., Sharer, L., Jacinto, S., and Cuenca, R. Aluminum Phagocytosis in Quadriceps Muscle following
Vaccination in Children: Relationship to Macrophagic Myofasciitis Pediatr.Dev.Pathol. 2002, 5 (2): 151­158.
Lane, J. M. Smallpox and Smallpox Vaccination N.Engl.J.Med. 8­29­2002, 347 (9): 691­692.
Lathrop, S. L., Ball, R., Haber, P., Mootrey, G. T., Braun, M. M., Shadomy, S. V., Ellenberg, S. S., Chen, R. T., and Hayes, E. B. Adverse event reports
following vaccination for Lyme disease: December 1998­­July 2000 Vaccine. 2­22­2002, 20 (11­12): 1603­1608.
Lau, C.; Sisson, J. The Effectiveness of Intradermal Pre­Exposure Rabies Vaccination in an Australian Travel Medicine Clinic. J Travel.Med. 9 (6): 285­288;
November, 2002.
Laubereau B, Hermann M, Schmitt HJ, Weil J, von Kries R. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect.
2002 Apr;128(2):185­92.
Laubereau, B., Grote, V., Holscher, G., Holscher, B., Frye, C., Wichmann, H. E., and Heinrich, J. Vaccination Against Haemophilus Influenzae Type b and
Atopy in East German Schoolchildren Eur.J Med.Res. 9­30­2002, 7 (9): 387­392
Leask J. Vaccination and risk communication: Summary of a workshop, Arlington Virginia, USA, 5­6 October 2000. J Paediatr Child Health. 2002
Apr;38(2):124­8
Leask, J. and Chapman, S. 'The cold hard facts' immunisation and vaccine preventable diseases in Australia's newsprint media 1993­1998 Soc.Sci.Med. 2002,
54 (3): 445­457.
Leask, J. Vaccination and Risk Communication: Summary of a Workshop, Arlington Virginia, USA, 5­6 October 2000 J.Paediatr.Child Health 2002, 38 (2):
124­128.
Lee MS, Nokes DJ, Wu YC, Huang YH, Lu CF. Measles IgG seroprevalence prior to mass vaccination in Taiwan. Int J Infect Dis. 2002;6(1):42­47.
Lee, P. Y., Matchar, D. B., Clements, D. A., Huber, J., Hamilton, J. D., and Peterson, E. D. Economic Analysis of Influenza Vaccination and Antiviral
Treatment for Healthy Working Adults Ann.Intern.Med. 2002, %20;137 (4): 225­231.
Levenson, D. Infant Immunizations Don't Increase Risk of Certain Illnesses, Panel Says Rep.Med.Guidel.Outcomes.Res. 3­8­2002, 13 (5): 1­2, 5
Levenson, D. Pneumonia Vaccine Protocol Could Save Money and Lives Rep.Med.Guidel.Outcomes.Res. 3­8­2002, 13 (5): 5­7
Levitsky, J., Te, H. S., Faust, T. W., and Cohen, S. M. Varicella Infection Following Varicella Vaccination in a Liver Transplant Recipient. Am.J Transplant.
2002, 2 (9): 880­882.
Levy­Bruhl, D. [What place for BCG vaccination in France?] Arch.Pediatr. 2002, 9 (1): 1­3.
Levy­Bruhl, D., Perrocheau, A., Mora, M., Taha, M., Dromell­Chabrier, S., and Quatresous, I. Vaccination Campaign Following an Increase in Incidence of
Serogroup C Meningococcal Diseases in the Department of Puy­De­Dome (France). Euro.Surveill 2002, 7 (5): 74­76.
Libman, M. D., Ibrahim, S. A., Omer, M. I., Adlan, I. A., Bellavance, F., Hoskins, E., Bertley, F., and Ward, B. J. No evidence for short or long term
morbidity after increased titer measles vaccination in Sudan Pediatr.Infect.Dis.J. 2002, 21 (2): 112­119.
Lista, F., Faggioni, G., Peragallo, M. S., Tontoli, F., Stella, A., Salvatori, P., Pusino, M., Germani, M. A., Contreas, V., and D'Amelio, R. Molecular analysis
of early postvaccine mumps­like disease in Italian military recruits JAMA. 3­6­2002, 287 (9): 1114­1115.
Liu, T. C., Chen, C. S., and Chen, L. M. The Impact of National Health Insurance on Neonatal Care Use and Childhood Vaccination in Taiwan Health Policy
Plan. 2002, 17 (4): 384­392
Luman, E. T., Barker, L. E., Simpson, D. M., Rodewald, L. E., Szilagyi, P. G., and Zhao, Z. National, State and Urban­Area Vaccination­Coverage Levels
Among Children Aged 19­35 Months, United States, 1999 Am.J.Prev.Med. 2001, 20 (4 Suppl): 88­153.
Lyratzopoulos, G., Aston, R., Bailey, K., Flitcroft, J., and Clarke, H. Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental
Recall of Vaccination Commun.Dis.Public Health 2002, 5 (4): 305­310.
Lyratzopoulos, G., Aston, R., Bailey, K., Flitcroft, J., and Clarke, H. Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental
Recall of Vaccination Commun.Dis.Public Health 2002, 5 (4): 305­310.
Mack, T. A Different View of Smallpox and Vaccination N.Engl.J Med. 2002 Dec 19, epub 1056/NEJMsb022994.
Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., and Melbye, M. A Population­Based Study of Measles,
Mumps, and Rubella Vaccination and Autism N.Engl.J Med. 11­7­2002, 347 (19): 1477­1482
Maiden MC, Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate olysaccharide vaccination. Lancet. 2002 May
25;359(9320):1829­31.
Maiden, M. C. and Stuart, J. M. Carriage of Serogroup C Meningococci 1 Year After Meningococcal C Conjugate Polysaccharide Vaccination Lancet 5­25­
2002, 359 (9320): 1829­1831.
Makela, A., Nuorti, J. P., and Peltola, H. Neurologic Disorders After Measles­Mumps­Rubella Vaccination Pediatrics 2002, 110 (5): 957­963
Makela, A., Nuorti, J. P., and Peltola, H. Neurologic Disorders After Measles­Mumps­Rubella Vaccination. Pediatrics 2002, 110 (5): 957­963.
Maldonado, Y. A. Current Controversies in Vaccination: Vaccine Safety JAMA 12­25­2002, 288 (24): 3155­3158.
Manuel, D. G., Henry, B., Hockin, J., and Naus, M. Health Behavior Associated With Influenza Vaccination Among Healthcare Workers in Long­Term­Care
Facilities. Infect.Control Hosp.Epidemiol. 2002, 23 (10): 609­614.
Mariat, C., Alamartine, E., Sabido, O., and Berthoux, F. Use of Mature Dendritic Cells for Anti­Human Papillomavirus Peptide­Based Vaccination in
Transplant Patients Transplant.Proc. 2002, 34 (7): 2836­2837
Marshall, B.C., Henshaw, C., Evans, D.A., Bleyl, K., Alder, S., T.G. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics 2002
May;109(5):E80­0